Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action.
Amerikanou C, Papada E, Gioxari A, Smyrnioudis I, Kleftaki SA, Valsamidou E, Bruns V, Banerjee R, Trivella MG, Milic N, Medić-Stojanoska M, Gastaldelli A, Kannt A; MAST4HEALTH; Dedoussis GV, Kaliora AC.
Amerikanou C, et al. Among authors: kleftaki sa.
Pharmacol Res. 2021 Sep;171:105753. doi: 10.1016/j.phrs.2021.105753. Epub 2021 Jul 2.
Pharmacol Res. 2021.
PMID: 34224858
Clinical Trial.